Well-Being After Breast Cancer Surgery (WB ABCs)
Primary Purpose
Coping Skills Training for Persistent Post-Surgical Pain, General Health Education
Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
CST-PSP
General health education
Sponsored by
About this trial
This is an interventional treatment trial for Coping Skills Training for Persistent Post-Surgical Pain
Eligibility Criteria
Inclusion Criteria:
- prior diagnosis of Stage 0 to III breast cancer, DCIS or LCiS
- received first breast cancer surgery (total or partial mastectomy, lumpectomy) at least 3 months ago
- reports score of ≥3 in the past month on the 0 to 10 breast pain severity and/or interference scale
- able to speak and read English
- able to provide meaningful consent
Exclusion Criteria:
- <18 years of age
- hearing impairment that limits use of videoconferencing for intervention sessions
- cognitive impairment that is documented in the medical record or results in being unable to provide meaningful consent
Sites / Locations
- Duke University Medical CenterRecruiting
- University of Pittsburgh Medical CenterRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Experimental
Active Comparator
Active Comparator
Arm Label
Coping Skills Training for Persistent Post-Surgical Pain
General health education with a coach
Self-guided health education
Arm Description
novel pain coping skills training intervention designed specifically for people with persistent pain (PP) following breast cancer surgery
general health education intervention
general health education intervention
Outcomes
Primary Outcome Measures
Change in PEG Pain Severity and Interference
Persistent post-surgical pain burden 3-item measure: average pain intensity (P); interference with enjoyment in life (E); interference with general activity (G)
Secondary Outcome Measures
Patient Health Questionnaire Depression Screener (PHQ-9)
9-item assessment of depressive symptoms over the past two weeks
Impact of Event Scale (IES)
15-item measure of intrusive and avoidant cognition regarding breast cancer during the past week
Pain Catastrophizing Scale (PCS)
13-item assessment of the degree to which participants experience catastrophic thinking during painful experiences
Acceptance and Action Questionnaire (AAQ-II)
7-item questionnaire designed to measure psychological inflexibility
Central Sensitization Inventory (CSI)
25-item questionnaire designed to measure hypersensitivity to senses and signs of central sensitization
Pain sensitivity: Pressure pain thresholds
Designed to measure central hyperexcitability using a digital pressure algometer measured pressure that is first perceived as painful and recorded in kg
Central sensitization: Temporal summation
Designed to measure central pain mediation using weighted pinprick probes
Generalized Anxiety Disorder Screener (GAD-7)
7-item assessment of symptoms of anxiety over the past two weeks
Chronic Pain Self-Efficacy Scale: Function Self-Efficacy Subscale (FSE)
9-item questionnaire designed to measure chronic pain patients' perceived self-efficacy for engaging in activities
Full Information
NCT ID
NCT04225585
First Posted
January 3, 2020
Last Updated
September 25, 2023
Sponsor
Duke University
Collaborators
University of Pittsburgh Medical Center
1. Study Identification
Unique Protocol Identification Number
NCT04225585
Brief Title
Well-Being After Breast Cancer Surgery
Acronym
WB ABCs
Official Title
Improving Well-Being for Individuals With Persistent Pain After Surgery for Breast Cancer, Lobular Carcinoma in Situ, or Ductal Carcinoma in Situ: A Randomized Clinical Trial That Compares Three Behavioral Intervention Strategies and Examines Psychological Factors as Drivers of the Continuing Burden of Persistent Pain
Study Type
Interventional
2. Study Status
Record Verification Date
September 2023
Overall Recruitment Status
Recruiting
Study Start Date
June 8, 2021 (Actual)
Primary Completion Date
April 30, 2025 (Anticipated)
Study Completion Date
April 30, 2025 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Duke University
Collaborators
University of Pittsburgh Medical Center
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this study is to compare the benefits of skills training and health education interventions designed specifically to increase the well-being of people with persistent pain after breast surgery for lobular carcinoma in situ (LCIS), ductal carcinoma in situ (DCIS), or invasive breast cancer, and to examine the roles of psychological and physiological variables as modifiable contributors to the continuing burden of persistent pain.
Detailed Description
Persistent pain following breast surgery for lobular carcinoma in situ (LCIS), ductal carcinoma in situ (DCIS), or invasive breast cancer is increasingly recognized as an important clinical and public health issue due to the large number of women affected, the powerful negative impact that persistent pain has on emotional and physical functioning and its financial costs. Most of the more than a quarter of a million women newly diagnosed with breast cancer in the U.S. this year will undergo surgery as a part of curative treatment. The prevalence of persistent pain following surgical removal of the affected breast (mastectomy) or more limited surgeries (lumpectomy) is high, ranging from 25-60% across studies. Unlike acute post-operative pain, which is a normal response to surgical trauma, persistent pain at or near the surgical site has an uncertain multifaceted etiology, and no satisfactory pharmacological treatment. A critical question is whether key pain-related psychosocial factors are drivers of the continuing burden of persistent pain, and whether they could be ameliorated by non-pharmacological intervention. The research planned under this award will provide a first critical test of the hypothesized driving role of pain catastrophizing in persistent pain after breast surgery. It also will explore the role of two other key psychosocial variables that may contribute to the burden associated with persistent pain after breast cancer surgery: self-efficacy for engaging in valued activities and psychological inflexibility. We have developed, manualized, and pilot tested a pain coping skills training intervention that specifically targets the needs of women with persistent pain following breast cancer surgery (CST-PSP) and aims to reduce pain catastrophizing, increase self-efficacy for engaging in valued activities, and increase psychological flexibility. We propose a multiple-site, randomized clinical trial to evaluate the efficacy of the CST-PSP intervention, as well as a health education intervention. The study will be conducted in diverse oncology clinics affiliated with Duke University/Duke Cancer Network and the University of Pittsburgh/UPMC Hillman Cancer Center. Participants (N=564) will be randomized to either receive: 1) CST-PSP, 2) health education with an interventionist, or 3) self-guided health education . Participants will complete assessments pre-intervention and at 3 months (post-intervention), 6 months follow-up, and 12 months follow-up. Study aims are: Aim 1: Examine the impact of intervention programs on persistent post-surgical pain severity and interference (i.e., PEG score), emotional distress (anxiety and depression), and cancer-specific distress. Aim 2: Investigate the impact of intervention programs on pain catastrophizing, pain self-efficacy, and psychological inflexibility, and evaluate these variables as possible mediators of the intervention benefits. Aim 3: Evaluate the impact of intervention programs on pain sensitivity and central sensitization, and explore whether changes in these variables mediate group differences in pain severity and interference.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Coping Skills Training for Persistent Post-Surgical Pain, General Health Education
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Masking Description
Study staff conducting assessments will be blind to group assignment. To maintain blinding, we will use the following approaches: 1) all study staff will be trained on the importance of blinding and study procedures to maintain blinding; 2) participants will be provided with the rationale and instructions not to disclose their group assignment; 3) the study staff who conduct post-intervention assessments will not be given information about group assignment prior to the assessment; and 4) if a breach occurs, it will be documented and the participant will complete their assessment with a new assessor.
Allocation
Randomized
Enrollment
307 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Coping Skills Training for Persistent Post-Surgical Pain
Arm Type
Experimental
Arm Description
novel pain coping skills training intervention designed specifically for people with persistent pain (PP) following breast cancer surgery
Arm Title
General health education with a coach
Arm Type
Active Comparator
Arm Description
general health education intervention
Arm Title
Self-guided health education
Arm Type
Active Comparator
Arm Description
general health education intervention
Intervention Type
Behavioral
Intervention Name(s)
CST-PSP
Other Intervention Name(s)
Coping Skills Training for Persistent Post-Surgical Pain
Intervention Description
skills training and experiential learning exercises
Intervention Type
Behavioral
Intervention Name(s)
General health education
Intervention Description
general health education intervention that focuses on improving overall health
Primary Outcome Measure Information:
Title
Change in PEG Pain Severity and Interference
Description
Persistent post-surgical pain burden 3-item measure: average pain intensity (P); interference with enjoyment in life (E); interference with general activity (G)
Time Frame
Baseline, 3 months, 6 months, 12 months
Secondary Outcome Measure Information:
Title
Patient Health Questionnaire Depression Screener (PHQ-9)
Description
9-item assessment of depressive symptoms over the past two weeks
Time Frame
Baseline, 3 months, 6 months, 12 months
Title
Impact of Event Scale (IES)
Description
15-item measure of intrusive and avoidant cognition regarding breast cancer during the past week
Time Frame
Baseline, 3 months, 6 months, 12 months
Title
Pain Catastrophizing Scale (PCS)
Description
13-item assessment of the degree to which participants experience catastrophic thinking during painful experiences
Time Frame
Baseline, 3 months, 6 months, 12 months
Title
Acceptance and Action Questionnaire (AAQ-II)
Description
7-item questionnaire designed to measure psychological inflexibility
Time Frame
Baseline, 3 months, 6 months, 12 months
Title
Central Sensitization Inventory (CSI)
Description
25-item questionnaire designed to measure hypersensitivity to senses and signs of central sensitization
Time Frame
Baseline, 3 months, 6 months, 12 months
Title
Pain sensitivity: Pressure pain thresholds
Description
Designed to measure central hyperexcitability using a digital pressure algometer measured pressure that is first perceived as painful and recorded in kg
Time Frame
Baseline, 6 months, 12 months
Title
Central sensitization: Temporal summation
Description
Designed to measure central pain mediation using weighted pinprick probes
Time Frame
Baseline, 6 months, 12 months
Title
Generalized Anxiety Disorder Screener (GAD-7)
Description
7-item assessment of symptoms of anxiety over the past two weeks
Time Frame
Baseline, 3 months, 6 months, 12 months
Title
Chronic Pain Self-Efficacy Scale: Function Self-Efficacy Subscale (FSE)
Description
9-item questionnaire designed to measure chronic pain patients' perceived self-efficacy for engaging in activities
Time Frame
Baseline, 3 months, 6 months, 12 months
Other Pre-specified Outcome Measures:
Title
Patient Healthcare Utilization
Description
6-item self-report of time spent utilizing healthcare in the past 4 weeks, as well as medication use and time spent on the intervention
Time Frame
Baseline, 1 month, 2 months, 3 months, 4 months, 5 months, 6 months, 9 months, 12 months
Title
Five-level EuroQoL-5 Dimensions (5L EQ-5D)
Description
5-item assessment of current health utility, plus 0 to 100 rating of overall health; QALYS will be derived from utility estimates
Time Frame
Baseline, 3 months, 6 months, 12 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
prior diagnosis of Stage 0 to III breast cancer, DCIS or LCiS
received first breast cancer surgery (total or partial mastectomy, lumpectomy) at least 3 months ago
reports score of ≥3 in the past month on the 0 to 10 breast pain severity and/or interference scale
able to speak and read English
able to provide meaningful consent
Exclusion Criteria:
<18 years of age
hearing impairment that limits use of videoconferencing for intervention sessions
cognitive impairment that is documented in the medical record or results in being unable to provide meaningful consent
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Rebecca Shelby, PhD
Phone
919-416-3410
Email
rebecca.shelby@duke.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Dana Bovbjerg, PhD
Phone
412-623-5965
Email
bovbjergdh@upmc.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Rebecca Shelby, PhD
Organizational Affiliation
Duke University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Dana Bovbjerg, PhD
Organizational Affiliation
University of Pittsburgh Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Duke University Medical Center
City
Durham
State/Province
North Carolina
ZIP/Postal Code
27705
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Rebecca Shelby, PhD
Phone
919-416-3410
Email
rebecca.shelby@duke.edu
First Name & Middle Initial & Last Name & Degree
Rebecca Shelby, PhD
Facility Name
University of Pittsburgh Medical Center
City
Pittsburgh
State/Province
Pennsylvania
ZIP/Postal Code
15232
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Dana Bovbjerg, PhD
Phone
412-623-5965
Email
bovbjergdh@upmc.edu
First Name & Middle Initial & Last Name & Degree
Dana Bovbjerg, PhD
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
36152791
Citation
Stalls JM, Bovbjerg DH, Somers TJ, Plumb Vilardaga JC, Kimmick GG, McAuliffe PF, Keefe FJ, Posluszny DM, Sullivan MJL, Erkanli A, Reed SD, Sutton L, Owen L, Massa L, Shelby RA. Improving well-being for individuals with persistent pain after surgery for breast cancer, lobular carcinoma in situ, or ductal carcinoma in situ: A randomized clinical trial. Contemp Clin Trials. 2022 Nov;122:106934. doi: 10.1016/j.cct.2022.106934. Epub 2022 Sep 21.
Results Reference
derived
Learn more about this trial
Well-Being After Breast Cancer Surgery
We'll reach out to this number within 24 hrs